Nano X Imaging Ltd., a leader in innovative medical imaging technology, announced that its U.S.-based subsidiary, Nanox Impact Inc., has signed a distribution agreement with NuvioDx LLC (NuvioDx), an imaging solutions provider focused on expanding access to diagnostic imaging, to support the deployment of Nanox.ARC systems.

This agreement represents Nanox’s growing distribution framework announced in 2026, following recent agreements, as the company continues to advance its channel partner strategy and build a diversified distribution network across the United States.

Under the terms of the agreement, NuvioDx will support the deployment of Nanox.ARC multi-source digital tomosynthesis systems across clinical sites in various states. The collaboration reflects Nanox’s strategy of working with partners that bring regional market access and operational capabilities to support system deployment and sustained utilisation.

The Nanox.ARC is an FDA-cleared, multisource digital tomosynthesis system that makes 3D imaging possible in more clinical settings, at a lower cost and reduced radiation dose compared to traditional CT.

“This collaboration represents an important step in strengthening our commercialisation strategy and expanding our channel partner network,” said Erez Meltzer, Chief Executive Officer and Acting Chairman of Nanox. “NuvioDX brings meaningful experience in supporting market adoption of innovative medical imaging technologies, which aligns with our efforts to broaden access to imaging.”

“NuvioDX is excited about the opportunity to partner with Nano X Imaging Ltd. and bring cutting-edge, innovative healthcare technology solutions to the marketplace,” said Richard Gastineau, Managing Director of NuvioDx LLC. “We believe Nano X Imaging Ltd.’s technology is strongly positioned to help providers enhance patient care, improve outcomes, and ultimately contribute to a better quality of life for the communities they serve.”